APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sickle Cell Anemia Therapeutics

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

Selected research

Industry Growth & Trends

Global Sickle Cell Anemia Therapeutics Industry Growth and Trends Forecast to 2032

21 December 2025113 pages

Choose your research edition.

Industry ResearchSickle Cell Anemia Therapeutics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Sickle Cell Anemia Therapeutics Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Sickle Cell Anemia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sickle Cell Anemia Therapeutics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sickle Cell Anemia Therapeutics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

According to APO Research, the global Sickle Cell Anemia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Sickle Cell Anemia Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sickle Cell Anemia Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sickle Cell Anemia Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sickle Cell Anemia Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Sickle Cell Anemia Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sickle Cell Anemia Therapeutics Market by Company

Emmaus Medical

Addmedica

Gamida Cell

GlycoMimetics

Pfizer

Novartis

Global Blood Therapeutics

Micelle BioPharma

Bluebird Bio

Prolong Pharmaceuticals

Modus Therapeutics

Sangamo Biosciences

Bioverativ

Imara

Ironwood Pharmaceuticals

Sickle Cell Anemia Therapeutics Segment by Type

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

Sickle Cell Anemia Therapeutics Segment by Application

Child

Adult

Sickle Cell Anemia Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sickle Cell Anemia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sickle Cell Anemia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sickle Cell Anemia Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Sickle Cell Anemia Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Sickle Cell Anemia Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Sickle Cell Anemia Therapeutics Market Share by Region (2021-2026) Table 4. Global Sickle Cell Anemia Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Sickle Cell Anemia Therapeutics Market Share by Region (2027-2032) Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2026) Table 9. Global Sickle Cell Anemia Therapeutics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Sickle Cell Anemia Therapeutics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Sickle Cell Anemia Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Sickle Cell Anemia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2026) Table 24. Global Sickle Cell Anemia Therapeutics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Sickle Cell Anemia Therapeutics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Sickle Cell Anemia Therapeutics Industry Trends Table 37. Sickle Cell Anemia Therapeutics Industry Drivers Table 38. Sickle Cell Anemia Therapeutics Industry Opportunities and Challenges Table 39. Sickle Cell Anemia Therapeutics Industry Restraints Table 40. Global Sickle Cell Anemia Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Company (2021-2026) Table 42. Global Sickle Cell Anemia Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Sickle Cell Anemia Therapeutics Key Company Headquarters & Area Served Table 44. Global Sickle Cell Anemia Therapeutics Company, Product Type & Application Table 45. Global Sickle Cell Anemia Therapeutics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Emmaus Medical Company Information Table 49. Emmaus Medical Business Overview Table 50. Emmaus Medical Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Emmaus Medical Sickle Cell Anemia Therapeutics Product Portfolio Table 52. Emmaus Medical Recent Development Table 53. Addmedica Company Information Table 54. Addmedica Business Overview Table 55. Addmedica Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Addmedica Sickle Cell Anemia Therapeutics Product Portfolio Table 57. Addmedica Recent Development Table 58. Gamida Cell Company Information Table 59. Gamida Cell Business Overview Table 60. Gamida Cell Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Gamida Cell Sickle Cell Anemia Therapeutics Product Portfolio Table 62. Gamida Cell Recent Development Table 63. GlycoMimetics Company Information Table 64. GlycoMimetics Business Overview Table 65. GlycoMimetics Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GlycoMimetics Sickle Cell Anemia Therapeutics Product Portfolio Table 67. GlycoMimetics Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Sickle Cell Anemia Therapeutics Product Portfolio Table 72. Pfizer Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Sickle Cell Anemia Therapeutics Product Portfolio Table 77. Novartis Recent Development Table 78. Global Blood Therapeutics Company Information Table 79. Global Blood Therapeutics Business Overview Table 80. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio Table 82. Global Blood Therapeutics Recent Development Table 83. Micelle BioPharma Company Information Table 84. Micelle BioPharma Business Overview Table 85. Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Micelle BioPharma Sickle Cell Anemia Therapeutics Product Portfolio Table 87. Micelle BioPharma Recent Development Table 88. Bluebird Bio Company Information Table 89. Bluebird Bio Business Overview Table 90. Bluebird Bio Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bluebird Bio Sickle Cell Anemia Therapeutics Product Portfolio Table 92. Bluebird Bio Recent Development Table 93. Prolong Pharmaceuticals Company Information Table 94. Prolong Pharmaceuticals Business Overview Table 95. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio Table 97. Prolong Pharmaceuticals Recent Development Table 98. Modus Therapeutics Company Information Table 99. Modus Therapeutics Business Overview Table 100. Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Modus Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio Table 102. Modus Therapeutics Recent Development Table 103. Sangamo Biosciences Company Information Table 104. Sangamo Biosciences Business Overview Table 105. Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Portfolio Table 107. Sangamo Biosciences Recent Development Table 108. Bioverativ Company Information Table 109. Bioverativ Business Overview Table 110. Bioverativ Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bioverativ Sickle Cell Anemia Therapeutics Product Portfolio Table 112. Bioverativ Recent Development Table 113. Imara Company Information Table 114. Imara Business Overview Table 115. Imara Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Imara Sickle Cell Anemia Therapeutics Product Portfolio Table 117. Imara Recent Development Table 118. Ironwood Pharmaceuticals Company Information Table 119. Ironwood Pharmaceuticals Business Overview Table 120. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio Table 122. Ironwood Pharmaceuticals Recent Development Table 123. North America Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Sickle Cell Anemia Therapeutics Market Share by Country (2021-2026) Table 126. North America Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Sickle Cell Anemia Therapeutics Market Share Forecast by Country (2027-2032) Table 128. Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2021-2026) Table 131. Europe Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Sickle Cell Anemia Therapeutics Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Country (2021-2026) Table 136. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share Forecast by Country (2027-2032) Table 138. Latin America Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2021-2026) Table 141. Latin America Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Sickle Cell Anemia Therapeutics Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country (2021-2026) Table 146. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Sickle Cell Anemia Therapeutics Product Image Figure 3. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Sickle Cell Anemia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 5. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2025 VS 2032 Figure 6. Global Sickle Cell Anemia Therapeutics Market Share by Region (2021-2032) Figure 7. North America Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Blood Transfusion Image Figure 13. Global Blood Transfusion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pharmacotherapy Image Figure 15. Global Pharmacotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Bone Marrow Transplant Image Figure 17. Global Bone Marrow Transplant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Sickle Cell Anemia Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Sickle Cell Anemia Therapeutics Market Share by Type 2025 VS 2032 Figure 20. North America Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2032) Figure 21. Europe Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2032) Figure 23. Latin America Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Share by Type (2021-2032) Figure 25. Child Image Figure 26. Global Child Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Adult Image Figure 28. Global Adult Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Sickle Cell Anemia Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sickle Cell Anemia Therapeutics Market Share by Application 2025 VS 2032 Figure 31. North America Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2032) Figure 32. Europe Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2032) Figure 34. Latin America Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Sickle Cell Anemia Therapeutics Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Sickle Cell Anemia Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Sickle Cell Anemia Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Sickle Cell Anemia Therapeutics Market Share by Country (2021-2032) Figure 41. Europe Sickle Cell Anemia Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Sickle Cell Anemia Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2021-2032) Figure 44. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Country (2021-2032) Figure 47. Latin America Sickle Cell Anemia Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Sickle Cell Anemia Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2021-2032) Figure 50. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant
Applications
  • Child
  • Adult
Companies covered
  • Emmaus Medical
  • Addmedica
  • Gamida Cell
  • GlycoMimetics
  • Pfizer
  • Novartis
  • Global Blood Therapeutics
  • Micelle BioPharma
  • Bluebird Bio
  • Prolong Pharmaceuticals
  • Modus Therapeutics
  • Sangamo Biosciences
  • Bioverativ
  • Imara
  • Ironwood Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Sickle Cell Anemia Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Sickle Cell Anemia Therapeutics Market Size by Region (2021-2032)
  5. 1.4.1 Global Sickle Cell Anemia Therapeutics Market Size by Region (2021-2026)
  6. 1.4.2 Global Sickle Cell Anemia Therapeutics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Sickle Cell Anemia Therapeutics Market Size (2021-2032)
  8. 1.5.1 North America Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate (2021-2032)
2 Sickle Cell Anemia Therapeutics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Blood Transfusion
  3. 2.1.2 Pharmacotherapy
  4. 2.1.3 Bone Marrow Transplant
  5. 2.2 Global Sickle Cell Anemia Therapeutics Market Size by Type
  6. 2.2.1 Global Sickle Cell Anemia Therapeutics Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Sickle Cell Anemia Therapeutics Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Sickle Cell Anemia Therapeutics Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Sickle Cell Anemia Therapeutics Market Size by Regions
  10. 2.3.1 North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Type (2021-2026)
3 Sickle Cell Anemia Therapeutics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Child
  3. 3.1.2 Adult
  4. 3.2 Global Sickle Cell Anemia Therapeutics Market Size by Application
  5. 3.2.1 Global Sickle Cell Anemia Therapeutics Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Sickle Cell Anemia Therapeutics Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Sickle Cell Anemia Therapeutics Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Sickle Cell Anemia Therapeutics Market Size by Regions
  9. 3.3.1 North America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Sickle Cell Anemia Therapeutics Industry Trends
  2. 4.2 Sickle Cell Anemia Therapeutics Industry Drivers
  3. 4.3 Sickle Cell Anemia Therapeutics Industry Opportunities and Challenges
  4. 4.4 Sickle Cell Anemia Therapeutics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Sickle Cell Anemia Therapeutics Revenue (2021-2026)
  2. 5.2 Global Sickle Cell Anemia Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Sickle Cell Anemia Therapeutics Key Company Headquarters & Area Served
  4. 5.4 Global Sickle Cell Anemia Therapeutics Company, Product Type & Application
  5. 5.5 Global Sickle Cell Anemia Therapeutics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Sickle Cell Anemia Therapeutics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Sickle Cell Anemia Therapeutics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Sickle Cell Anemia Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Emmaus Medical
  2. 6.1.1 Emmaus Medical Company Information
  3. 6.1.2 Emmaus Medical Business Overview
  4. 6.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Emmaus Medical Sickle Cell Anemia Therapeutics Product Portfolio
  6. 6.1.5 Emmaus Medical Recent Developments
  7. 6.2 Addmedica
  8. 6.2.1 Addmedica Company Information
  9. 6.2.2 Addmedica Business Overview
  10. 6.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Addmedica Sickle Cell Anemia Therapeutics Product Portfolio
  12. 6.2.5 Addmedica Recent Developments
  13. 6.3 Gamida Cell
  14. 6.3.1 Gamida Cell Company Information
  15. 6.3.2 Gamida Cell Business Overview
  16. 6.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Gamida Cell Sickle Cell Anemia Therapeutics Product Portfolio
  18. 6.3.5 Gamida Cell Recent Developments
  19. 6.4 GlycoMimetics
  20. 6.4.1 GlycoMimetics Company Information
  21. 6.4.2 GlycoMimetics Business Overview
  22. 6.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GlycoMimetics Sickle Cell Anemia Therapeutics Product Portfolio
  24. 6.4.5 GlycoMimetics Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Sickle Cell Anemia Therapeutics Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Sickle Cell Anemia Therapeutics Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Global Blood Therapeutics
  38. 6.7.1 Global Blood Therapeutics Company Information
  39. 6.7.2 Global Blood Therapeutics Business Overview
  40. 6.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio
  42. 6.7.5 Global Blood Therapeutics Recent Developments
  43. 6.8 Micelle BioPharma
  44. 6.8.1 Micelle BioPharma Company Information
  45. 6.8.2 Micelle BioPharma Business Overview
  46. 6.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Portfolio
  48. 6.8.5 Micelle BioPharma Recent Developments
  49. 6.9 Bluebird Bio
  50. 6.9.1 Bluebird Bio Company Information
  51. 6.9.2 Bluebird Bio Business Overview
  52. 6.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bluebird Bio Sickle Cell Anemia Therapeutics Product Portfolio
  54. 6.9.5 Bluebird Bio Recent Developments
  55. 6.10 Prolong Pharmaceuticals
  56. 6.10.1 Prolong Pharmaceuticals Company Information
  57. 6.10.2 Prolong Pharmaceuticals Business Overview
  58. 6.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio
  60. 6.10.5 Prolong Pharmaceuticals Recent Developments
  61. 6.11 Modus Therapeutics
  62. 6.11.1 Modus Therapeutics Company Information
  63. 6.11.2 Modus Therapeutics Business Overview
  64. 6.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio
  66. 6.11.5 Modus Therapeutics Recent Developments
  67. 6.12 Sangamo Biosciences
  68. 6.12.1 Sangamo Biosciences Company Information
  69. 6.12.2 Sangamo Biosciences Business Overview
  70. 6.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Portfolio
  72. 6.12.5 Sangamo Biosciences Recent Developments
  73. 6.13 Bioverativ
  74. 6.13.1 Bioverativ Company Information
  75. 6.13.2 Bioverativ Business Overview
  76. 6.13.3 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bioverativ Sickle Cell Anemia Therapeutics Product Portfolio
  78. 6.13.5 Bioverativ Recent Developments
  79. 6.14 Imara
  80. 6.14.1 Imara Company Information
  81. 6.14.2 Imara Business Overview
  82. 6.14.3 Imara Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Imara Sickle Cell Anemia Therapeutics Product Portfolio
  84. 6.14.5 Imara Recent Developments
  85. 6.15 Ironwood Pharmaceuticals
  86. 6.15.1 Ironwood Pharmaceuticals Company Information
  87. 6.15.2 Ironwood Pharmaceuticals Business Overview
  88. 6.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio
  90. 6.15.5 Ironwood Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026)
  3. 7.3 North America Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026)
  3. 8.3 Europe Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026)
  3. 10.3 South America Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst